- Home
- ROIV vs FLS Comparison
ROIV vs FLS Comparison
Compare ROIV & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- FLS
- Stock Information
- Founded
- ROIV 2014
- FLS 1790
- Country
- ROIV United Kingdom
- FLS United States
- Employees
- ROIV N/A
- FLS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- FLS Fluid Controls
- Sector
- ROIV Health Care
- FLS Industrials
- Exchange
- ROIV Nasdaq
- FLS Nasdaq
- Market Cap
- ROIV 8.4B
- FLS 8.3B
- IPO Year
- ROIV N/A
- FLS N/A
- Fundamental
- Price
- ROIV $10.76
- FLS $52.11
- Analyst Decision
- ROIV Buy
- FLS Strong Buy
- Analyst Count
- ROIV 4
- FLS 9
- Target Price
- ROIV $17.50
- FLS $64.11
- AVG Volume (30 Days)
- ROIV 5.9M
- FLS 1.8M
- Earning Date
- ROIV 05-29-2025
- FLS 04-29-2025
- Dividend Yield
- ROIV N/A
- FLS 1.60%
- EPS Growth
- ROIV N/A
- FLS 20.22
- EPS
- ROIV N/A
- FLS 2.14
- Revenue
- ROIV $122,585,000.00
- FLS $4,614,870,000.00
- Revenue This Year
- ROIV N/A
- FLS $6.43
- Revenue Next Year
- ROIV N/A
- FLS $3.77
- P/E Ratio
- ROIV N/A
- FLS $24.46
- Revenue Growth
- ROIV 140.04
- FLS 4.23
- 52 Week Low
- ROIV $8.73
- FLS $37.34
- 52 Week High
- ROIV $13.06
- FLS $65.08
- Technical
- Relative Strength Index (RSI)
- ROIV 49.33
- FLS 69.85
- Support Level
- ROIV $10.58
- FLS $46.34
- Resistance Level
- ROIV $11.77
- FLS $47.89
- Average True Range (ATR)
- ROIV 0.34
- FLS 1.37
- MACD
- ROIV -0.05
- FLS 0.98
- Stochastic Oscillator
- ROIV 15.13
- FLS 96.73
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.